We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.9B
AUM Growth
+$373M
Cap. Flow
+$123M
Cap. Flow %
0.82%
Top 10 Hldgs %
56.71%
Holding
1,166
New
198
Increased
342
Reduced
449
Closed
173

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$32M
2
AVGO icon
Broadcom
AVGO
+$31.6M
3
VZ icon
Verizon
VZ
+$27.3M
4
CCJ icon
Cameco
CCJ
+$26.1M
5
MPLX icon
MPLX
MPLX
+$23.1M

Sector Composition

Rank Sector Weight
1 Energy 66.42%
2 Technology 4.66%
3 Financials 3.55%
4 Consumer Discretionary 3.47%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
326
DELISTED
Amicus Therapeutics
FOLD
$2.42M 0.02%
227,053
-3,984
-2% -$43.4K
FTNT icon
327
Fortinet
FTNT
$112B
$2.42M 0.02%
31,246
-2,969
-9% -$203K
PLTR icon
328
Palantir
PLTR
$295B
$2.42M 0.02%
65,118
-6,988
-10% -$214K
TELL
329
DELISTED
Tellurian Inc.
TELL
$2.4M 0.02%
2,481,398
+742,019
+43% +$641K
SHOP icon
330
Shopify
SHOP
$148B
$2.38M 0.02%
29,711
+682
+2% +$47.1K
NFG icon
331
National Fuel Gas
NFG
$7.84B
$2.38M 0.02%
39,270
+16,813
+75% +$983K
HSY icon
332
Hershey
HSY
$35.4B
$2.37M 0.02%
12,333
+6,129
+99% +$1.19M
CSX icon
333
CSX Corp
CSX
$98.6B
$2.35M 0.02%
67,999
-26,094
-28% -$886K
WTRG icon
334
Essential Utilities
WTRG
$11.2B
$2.34M 0.02%
60,713
-6,223
-9% -$245K
PTGX icon
335
Protagonist Therapeutics
PTGX
$8.75B
$2.34M 0.02%
52,032
+6,260
+14% +$253K
AXP icon
336
American Express
AXP
$223B
$2.27M 0.02%
8,369
-1,944
-19% -$484K
XENE icon
337
Xenon Pharmaceuticals
XENE
$6.32B
$2.24M 0.02%
56,989
-1,864
-3% -$75.2K
REYN icon
338
Reynolds Consumer Products
REYN
$5.4B
$2.23M 0.01%
71,639
+27,151
+61% +$804K
PNW icon
339
Pinnacle West Capital
PNW
$12.9B
$2.21M 0.01%
24,976
-3,643
-13% -$311K
APP icon
340
Applovin
APP
$132B
$2.21M 0.01%
16,928
-5,802
-26% -$529K
MLTX icon
341
MoonLake Immunotherapeutics
MLTX
$1.59B
$2.21M 0.01%
43,828
-5,214
-11% -$244K
DE icon
342
Deere & Co
DE
$170B
$2.2M 0.01%
5,261
-8,024
-60% -$3.03M
SNA icon
343
Snap-on
SNA
$20.9B
$2.18M 0.01%
7,508
+3,962
+112% +$1.09M
GWRE icon
344
Guidewire Software
GWRE
$11.5B
$2.16M 0.01%
11,817
+3,852
+48% +$585K
PTCT icon
345
PTC Therapeutics
PTCT
$6.37B
$2.16M 0.01%
58,169
-1,649
-3% -$55.2K
MELI icon
346
Mercado Libre
MELI
$91.3B
$2.14M 0.01%
1,044
-283
-21% -$533K
KMB icon
347
Kimberly-Clark
KMB
$36.4B
$2.14M 0.01%
15,043
+5,378
+56% +$763K
FIS icon
348
Fidelity National Information Services
FIS
$21.5B
$2.11M 0.01%
25,216
-4,461
-15% -$352K
MDLZ icon
349
Mondelez International
MDLZ
$77.7B
$2.11M 0.01%
28,614
-16,397
-36% -$1.15M
GWW icon
350
W.W. Grainger
GWW
$65.3B
$2.09M 0.01%
2,014
-381
-16% -$369K

Similar funds

ALPS Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, ALPS Advisors held 1,166 positions worth $14.9B, up 2.6% from $14.6B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

ALPS Advisors's Q3 2024 filing shows 198 new, 342 increased, 449 reduced and 173 closed positions. Its largest new stake was LyondellBasell Industries: 258,651 shares worth $24.8M. The largest sale was JPMorgan Chase, an estimated $32M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 69% a quarter earlier, followed by Technology and Financials.

  • ALPS Advisors's largest Q3 2024 buy was LyondellBasell Industries: 258,651 shares worth $24.8M.
  • ALPS Advisors added most to ENLINK MIDSTREAM, LLC in Q3 2024, an estimated $48.3M increase.
  • ALPS Advisors's biggest Q3 2024 reduction was JPMorgan Chase, cutting an estimated $32M.
  • ALPS Advisors fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $14.5M.
  • ALPS Advisors's ten largest holdings make up 57% of its $14.9B portfolio in Q3 2024.
  • ALPS Advisors opened 198 new positions and closed 173 in Q3 2024.
  • ALPS Advisors's portfolio value rose 2.6% quarter-over-quarter to $14.9B.

Based on ALPS Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.